Clinical Trials Directory

Trials / Completed

CompletedNCT02785653

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium Under Routine Clinical Practice

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Maharashtra University of Health Sciences · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the potentiation of muscle relaxation caused by rocuronium by inhalational agent sevoflurane. Half the patients will be ventilated with oxygen ,nitrous oxide and sevoflurane during induction of anaesthesia and half will be ventilated only with oxygen and nitrous oxide.

Detailed description

Rocuronium is a non depolarizing muscle relaxant. Inhalational general anaesthetic agents like Sevoflurane have some muscle relaxation effect by depressing the spinal motor neurons. Inhalational anaesthetics also alter the tonic input received from descending modulatory systems from the brain. Deep anaesthesia with inhalational agents may cause some degree of neuromuscular blockade.

Conditions

Interventions

TypeNameDescription
DRUGSevofluranePatients were ventilated with 2 % inspired concentration of sevoflurane in a fresh gas flow of 5 litres containing 66.6% nitrous oxide and 33.3% percent of oxygen
DRUGRocuroniumrocuronium 0.6mg per kg body weight was given intravenously after induction of anaesthesia

Timeline

Start date
2004-04-01
Primary completion
2006-11-01
Completion
2006-11-01
First posted
2016-05-30
Last updated
2016-06-09

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02785653. Inclusion in this directory is not an endorsement.